Cargando…

Enhancing the efficacy of immunotherapy using radiotherapy

Recent clinical breakthroughs in cancer immunotherapy, especially with immune checkpoint blockade, offer great hope for cancer sufferers – and have greatly changed the landscape of cancer treatment. However, whilst many patients achieve clinical responses, others experience minimal benefit or do not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keam, Synat, Gill, Suki, Ebert, Martin A, Nowak, Anna K, Cook, Alistair M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507442/ https://www.ncbi.nlm.nih.gov/pubmed/32994997 http://dx.doi.org/10.1002/cti2.1169

Ejemplares similares

Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
por: Gill, Suki, et al.
Publicado: (2022)

Immune marker expression of irradiated mesothelioma cell lines
por: Chang, Faith, et al.
Publicado: (2022)

Effects of Photon Radiation on DNA Damage, Cell Proliferation, Cell Survival, and Apoptosis of Murine and Human Mesothelioma Cell Lines
por: Keam, Synat, et al.
Publicado: (2022)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
por: Kang, Synat, et al.
Publicado: (2021)

Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma
por: Matsui, Jennifer K., et al.
Publicado: (2022)

Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity
por: Gao, Zhiru, et al.
Publicado: (2023)

Leveraging epigenetics to enhance the efficacy of immunotherapy
por: Licht, Jonathan D., et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19): A literature review
por: Harapan, Harapan, et al.
Publicado: (2020)

Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies
por: Cook, Alistair M., et al.
Publicado: (2015)

Radiotherapy and Immunotherapy in Lung Cancer
por: Hsieh, Kristin, et al.
Publicado: (2023)

Immunotherapy as sensitizer for local radiotherapy
por: Vanneste, Ben G.L., et al.
Publicado: (2020)

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine
por: Hagan, C. Tilden, et al.
Publicado: (2020)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

Risk of cardiac implantable device malfunction in cancer patients receiving proton therapy: an overview
por: Mirzaei, Milad, et al.
Publicado: (2023)

Radiotherapy–immunotherapy combinations – perspectives and challenges
por: Mondini, Michele, et al.
Publicado: (2020)

Radiotherapy: Brightness and darkness in the era of immunotherapy
por: Zhai, Danyi, et al.
Publicado: (2022)

Combinations of radiotherapy with immunotherapy in cervical cancer
por: Yang, Xiaojing, et al.
Publicado: (2022)

Predictors of clinical response to immunotherapy with or without radiotherapy
por: Hiniker, Susan M., et al.
Publicado: (2015)

The role of radiotherapy in the age of immunotherapy
por: Sato, Hiro, et al.
Publicado: (2021)

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023)

Comparison of conventional versus customised Eurosil-4 Pink bolus for radiotherapy of the chest wall
por: Gill, Ashlesha, et al.
Publicado: (2022)

Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017)

Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
por: Shi, Lewis Zhichang, et al.
Publicado: (2021)

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
por: De Wolf, Katrien, et al.
Publicado: (2015)

Ten-year results of quality assurance in radiotherapy chart round
por: Taghavi Bayat, Bardia, et al.
Publicado: (2013)

What benefit could be derived from on-line adaptive prostate radiotherapy using rectal diameter as a predictor of motion?
por: Oates, Richard, et al.
Publicado: (2015)

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
por: Bhave, Prachi, et al.
Publicado: (2023)

Pre-immunotherapy radiotherapy enhanced the efficacy of multi-line sintilimab in unresectable advanced esophageal squamous cell carcinoma
por: Xu, Shuhui, et al.
Publicado: (2023)

Allergen-Specific Immunotherapies for Food Allergy
por: Feuille, Elizabeth, et al.
Publicado: (2018)

Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification Inhibitors
por: Sun, Wanyu, et al.
Publicado: (2018)

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
por: Zhang, Zengfu, et al.
Publicado: (2022)

Fundamentals to clinical application of nanoparticles in cancer immunotherapy and radiotherapy
por: Selvaraja, Vinodh Kumar, et al.
Publicado: (2020)

Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy
por: Kabiljo, Julijan, et al.
Publicado: (2019)

Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy
por: Dong, Qingrong, et al.
Publicado: (2023)

The confluence of radiotherapy and immunotherapy
por: Burnette, Byron, et al.
Publicado: (2012)

Mechanisms of synergy of radiotherapy and immunotherapy
por: Pilones, Karsten A, et al.
Publicado: (2015)

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
por: Kershaw, Michael H, et al.
Publicado: (2013)

Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy
por: Marcus, Damiënne, et al.
Publicado: (2021)

Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism?
por: Wang, Jiaqiang, et al.
Publicado: (2023)

Cancer 6. A Comprehensive Treatise. Radiotherapy, Surgery and Immunotherapy
por: Hendry, J. H., et al.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_8h9ac59jmjf1b7gjac99ikcj7n